Outlook Therapeutics Inc (OTLK)

[H2R]

Another slice at $1.48

I don't understand the PPS drop today, over 7%. I checked the news, nothing weird.
https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeuticsr-reports-financial-results-third-quarter
The 3rd quarter report is what's expected, with the PDUFA date kept on Aug. 29th.

Upcoming Anticipated Milestones

> PDUFA goal date of August 29, 2023;
> Evaluation of ONS-5010 in a pre-filled syringe in the NORSE SEVEN clinical trial expected to be complete in 2024; and
> MAA decision date from the EMA’s CHMP in the EU for ONS-5010 expected in first half of 2024.

So all on track. Plus

Commercial Planning Underway to Support Potential Approval of the First Ophthalmic Formulation of Bevacizumab for Use in Retinal Indications

So I got myself another slide. If I'm wrong, it's going to sting a bit. I rely on known facts.

Best of luck with your investments!